United States Crohn Disease Market Report 2017

October 2017 | 101 pages | ID: U718D55379AEN
QYResearch

Abstracts

In this report, the United States Crohn Disease market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Crohn Disease in these regions, from 2012 to 2022 (forecast).

United States Crohn Disease market competition by top manufacturers/players, with Crohn Disease sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AbbVie
• Janssen Biotech
• Takeda Pharmaceuticals
• UCB
• Amgen
• Tillotts Pharma

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Aminosalicylates (5-ASA)
• Corticosteroids
• Immunomodulators
• Antibiotics

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Crohn Disease for each application, including

• Achieving remission (the absence of symptoms)
• Maintaining remission (prevention of flare-ups)
• Pediatric Crohn’s Disease

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Crohn Disease Market Report 2017

1 CROHN DISEASE OVERVIEW

1.1 Product Overview and Scope of Crohn Disease
1.2 Classification of Crohn Disease by Product Category
  1.2.1 United States Crohn Disease Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Crohn Disease Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Aminosalicylates (5-ASA)
  1.2.4 Corticosteroids
  1.2.5 Immunomodulators
  1.2.6 Antibiotics
1.3 United States Crohn Disease Market by Application/End Users
  1.3.1 United States Crohn Disease Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Achieving remission (the absence of symptoms)
  1.3.3 Maintaining remission (prevention of flare-ups)
  1.3.4 Pediatric Crohn’s Disease
1.4 United States Crohn Disease Market by Region
  1.4.1 United States Crohn Disease Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Crohn Disease Status and Prospect (2012-2022)
  1.4.3 Southwest Crohn Disease Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Crohn Disease Status and Prospect (2012-2022)
  1.4.5 New England Crohn Disease Status and Prospect (2012-2022)
  1.4.6 The South Crohn Disease Status and Prospect (2012-2022)
  1.4.7 The Midwest Crohn Disease Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Crohn Disease (2012-2022)
  1.5.1 United States Crohn Disease Sales and Growth Rate (2012-2022)
  1.5.2 United States Crohn Disease Revenue and Growth Rate (2012-2022)

2 UNITED STATES CROHN DISEASE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Crohn Disease Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Crohn Disease Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Crohn Disease Average Price by Players/Suppliers (2012-2017)
2.4 United States Crohn Disease Market Competitive Situation and Trends
  2.4.1 United States Crohn Disease Market Concentration Rate
  2.4.2 United States Crohn Disease Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Crohn Disease Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CROHN DISEASE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Crohn Disease Sales and Market Share by Region (2012-2017)
3.2 United States Crohn Disease Revenue and Market Share by Region (2012-2017)
3.3 United States Crohn Disease Price by Region (2012-2017)

4 UNITED STATES CROHN DISEASE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Crohn Disease Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Crohn Disease Revenue and Market Share by Type (2012-2017)
4.3 United States Crohn Disease Price by Type (2012-2017)
4.4 United States Crohn Disease Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CROHN DISEASE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Crohn Disease Sales and Market Share by Application (2012-2017)
5.2 United States Crohn Disease Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CROHN DISEASE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AbbVie
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Crohn Disease Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbVie Crohn Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Janssen Biotech
  6.2.2 Crohn Disease Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Janssen Biotech Crohn Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Takeda Pharmaceuticals
  6.3.2 Crohn Disease Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Takeda Pharmaceuticals Crohn Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 UCB
  6.4.2 Crohn Disease Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 UCB Crohn Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Amgen
  6.5.2 Crohn Disease Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amgen Crohn Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Tillotts Pharma
  6.6.2 Crohn Disease Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Tillotts Pharma Crohn Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 CROHN DISEASE MANUFACTURING COST ANALYSIS

7.1 Crohn Disease Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Crohn Disease

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Crohn Disease Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Crohn Disease Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CROHN DISEASE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Crohn Disease Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Crohn Disease Sales Volume Forecast by Type (2017-2022)
11.3 United States Crohn Disease Sales Volume Forecast by Application (2017-2022)
11.4 United States Crohn Disease Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Crohn Disease
Figure United States Crohn Disease Market Size (K Pcs) by Type (2012-2022)
Figure United States Crohn Disease Sales Volume Market Share by Type (Product Category) in 2016
Figure Aminosalicylates (5-ASA) Product Picture
Figure Corticosteroids Product Picture
Figure Immunomodulators Product Picture
Figure Antibiotics Product Picture
Figure United States Crohn Disease Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Crohn Disease by Application in 2016
Figure Achieving remission (the absence of symptoms) Examples
Table Key Downstream Customer in Achieving remission (the absence of symptoms)
Figure Maintaining remission (prevention of flare-ups) Examples
Table Key Downstream Customer in Maintaining remission (prevention of flare-ups)
Figure Pediatric Crohn’s Disease Examples
Table Key Downstream Customer in Pediatric Crohn’s Disease
Figure United States Crohn Disease Market Size (Million USD) by Region (2012-2022)
Figure The West Crohn Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Crohn Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Crohn Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Crohn Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Crohn Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Crohn Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Crohn Disease Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Crohn Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Crohn Disease Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Crohn Disease Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Crohn Disease Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Crohn Disease Sales Share by Players/Suppliers
Figure 2017 United States Crohn Disease Sales Share by Players/Suppliers
Figure United States Crohn Disease Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Crohn Disease Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Crohn Disease Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Crohn Disease Revenue Share by Players/Suppliers
Figure 2017 United States Crohn Disease Revenue Share by Players/Suppliers
Table United States Market Crohn Disease Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Crohn Disease Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Crohn Disease Market Share of Top 3 Players/Suppliers
Figure United States Crohn Disease Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Crohn Disease Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Crohn Disease Product Category
Table United States Crohn Disease Sales (K Pcs) by Region (2012-2017)
Table United States Crohn Disease Sales Share by Region (2012-2017)
Figure United States Crohn Disease Sales Share by Region (2012-2017)
Figure United States Crohn Disease Sales Market Share by Region in 2016
Table United States Crohn Disease Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Crohn Disease Revenue Share by Region (2012-2017)
Figure United States Crohn Disease Revenue Market Share by Region (2012-2017)
Figure United States Crohn Disease Revenue Market Share by Region in 2016
Table United States Crohn Disease Price (USD/Pcs) by Region (2012-2017)
Table United States Crohn Disease Sales (K Pcs) by Type (2012-2017)
Table United States Crohn Disease Sales Share by Type (2012-2017)
Figure United States Crohn Disease Sales Share by Type (2012-2017)
Figure United States Crohn Disease Sales Market Share by Type in 2016
Table United States Crohn Disease Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Crohn Disease Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Crohn Disease by Type (2012-2017)
Figure Revenue Market Share of Crohn Disease by Type in 2016
Table United States Crohn Disease Price (USD/Pcs) by Types (2012-2017)
Figure United States Crohn Disease Sales Growth Rate by Type (2012-2017)
Table United States Crohn Disease Sales (K Pcs) by Application (2012-2017)
Table United States Crohn Disease Sales Market Share by Application (2012-2017)
Figure United States Crohn Disease Sales Market Share by Application (2012-2017)
Figure United States Crohn Disease Sales Market Share by Application in 2016
Table United States Crohn Disease Sales Growth Rate by Application (2012-2017)
Figure United States Crohn Disease Sales Growth Rate by Application (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Crohn Disease Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Crohn Disease Sales Growth Rate (2012-2017)
Figure AbbVie Crohn Disease Sales Market Share in United States (2012-2017)
Figure AbbVie Crohn Disease Revenue Market Share in United States (2012-2017)
Table Janssen Biotech Basic Information List
Table Janssen Biotech Crohn Disease Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Janssen Biotech Crohn Disease Sales Growth Rate (2012-2017)
Figure Janssen Biotech Crohn Disease Sales Market Share in United States (2012-2017)
Figure Janssen Biotech Crohn Disease Revenue Market Share in United States (2012-2017)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Crohn Disease Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Takeda Pharmaceuticals Crohn Disease Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceuticals Crohn Disease Sales Market Share in United States (2012-2017)
Figure Takeda Pharmaceuticals Crohn Disease Revenue Market Share in United States (2012-2017)
Table UCB Basic Information List
Table UCB Crohn Disease Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure UCB Crohn Disease Sales Growth Rate (2012-2017)
Figure UCB Crohn Disease Sales Market Share in United States (2012-2017)
Figure UCB Crohn Disease Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Crohn Disease Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Crohn Disease Sales Growth Rate (2012-2017)
Figure Amgen Crohn Disease Sales Market Share in United States (2012-2017)
Figure Amgen Crohn Disease Revenue Market Share in United States (2012-2017)
Table Tillotts Pharma Basic Information List
Table Tillotts Pharma Crohn Disease Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Tillotts Pharma Crohn Disease Sales Growth Rate (2012-2017)
Figure Tillotts Pharma Crohn Disease Sales Market Share in United States (2012-2017)
Figure Tillotts Pharma Crohn Disease Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Crohn Disease
Figure Manufacturing Process Analysis of Crohn Disease
Figure Crohn Disease Industrial Chain Analysis
Table Raw Materials Sources of Crohn Disease Major Players/Suppliers in 2016
Table Major Buyers of Crohn Disease
Table Distributors/Traders List
Figure United States Crohn Disease Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Crohn Disease Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Crohn Disease Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Crohn Disease Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Crohn Disease Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Crohn Disease Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Crohn Disease Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Crohn Disease Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Crohn Disease Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Crohn Disease Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Crohn Disease Sales Volume Share Forecast by Region (2017-2022)
Figure United States Crohn Disease Sales Volume Share Forecast by Region (2017-2022)
Figure United States Crohn Disease Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources